These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 20430735)

  • 1. Correlation of c-erbB-2, EGF and EGFR expression with postoperative survival of patients with advanced carcinoma of the stomach.
    Czyzewska J; Guzinska-Ustymowicz K; Kemona A
    Folia Histochem Cytobiol; 2009; 47(4):653-61. PubMed ID: 20430735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori infection and expressions of EGF, EGFR and c-erbB-2 proteins in gastric carcinoma.
    Pryczynicz A; Guzińska-Ustymowicz K; Kemona A; Czyzewska J
    Folia Histochem Cytobiol; 2009 Jan; 47(3):447-51. PubMed ID: 20164030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of epidermal growth factors and apoptosis markers in pancreatic ductal adenocarcinoma.
    Pryczynicz A; Guzińska-Ustymowicz K; Czyzewska J; Kemona A
    Folia Histochem Cytobiol; 2009; 47(4):667-71. PubMed ID: 20430737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of EGF and EGFR strongly correlates with metastasis of pancreatic ductal carcinoma.
    Pryczynicz A; Guzińska-Ustymowicz K; Kemona A; Czyzewska J
    Anticancer Res; 2008; 28(2B):1399-404. PubMed ID: 18505086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of matrix metalloproteinase 9 and cathepsin B in gastric carcinoma is associated with lymph node metastasis, but not with postoperative survival.
    Czyzewska J; Guzińska-Ustymowicz K; Kemona A; Bandurski R
    Folia Histochem Cytobiol; 2008; 46(1):57-64. PubMed ID: 18296264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of E-cadherin-catenin complex in patients with advanced gastric cancer: role in formation of metastasis.
    Czyzewska J; Guzińska-Ustymowicz K; Ustymowicz M; Pryczynicz A; Kemona A
    Folia Histochem Cytobiol; 2010 Jan; 48(1):37-45. PubMed ID: 20529814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical expression of EGF, c-erbB-2 and EGFR in intestinal variant of gastric adenocarcinomas.
    Docea AO; Mitruţ P; Cernea D; Georgescu CC; Olimid D; Mărgăritescu C; Dumitrescu D
    Rom J Morphol Embryol; 2013; 54(3):545-54. PubMed ID: 24068402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical evaluation of Ki-67, PCNA and MCM2 proteins proliferation index (PI) in advanced gastric cancer.
    Czyzewska J; Guzińska-Ustymowicz K; Pryczynicz A; Kemona A; Bandurski R
    Folia Histochem Cytobiol; 2009; 47(2):289-96. PubMed ID: 19995716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-binding epidermal growth factor-like growth factor isoforms and epidermal growth factor receptor/ErbB1 expression in bladder cancer and their relation to clinical outcome.
    Kramer C; Klasmeyer K; Bojar H; Schulz WA; Ackermann R; Grimm MO
    Cancer; 2007 May; 109(10):2016-24. PubMed ID: 17394193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of epidermal growth factor (EGF), EGF receptor, and c-erbB-2 in human gastric cancer.
    Tokunaga A; Onda M; Okuda T; Teramoto T; Fujita I; Mizutani T; Kiyama T; Yoshiyuki T; Nishi K; Matsukura N
    Cancer; 1995 Mar; 75(6 Suppl):1418-25. PubMed ID: 7889468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study.
    Langer R; Von Rahden BH; Nahrig J; Von Weyhern C; Reiter R; Feith M; Stein HJ; Siewert JR; Höfler H; Sarbia M
    J Clin Pathol; 2006 Jun; 59(6):631-4. PubMed ID: 16731604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of epidermal growth factor-related peptides and type I receptor tyrosine kinase receptors with prognosis of human colorectal carcinomas.
    Saeki T; Salomon DS; Johnson GR; Gullick WJ; Mandai K; Yamagami K; Moriwaki S; Tanada M; Takashima S; Tahara E
    Jpn J Clin Oncol; 1995 Dec; 25(6):240-9. PubMed ID: 8523820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of Helicobacter pylori on EGF, EGF receptor, and the c-erb-B2 expression.
    Jurkowska G; Piotrowska-Staworko G; Guzińska-Ustymowicz K; Kemona A; Świdnicka-Siergiejko A; Łaszewicz W; Dąbrowski A
    Adv Med Sci; 2014 Sep; 59(2):221-6. PubMed ID: 25051417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor in gastric carcinoma as a risk factor of postoperative recurrence.
    Ichiyoshi Y; Tateishi M; Toda T; Minamizono Y; Nagasaki S; Yao T; Sugimachi K
    Int Surg; 1993; 78(3):196-9. PubMed ID: 8276539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
    Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
    J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-erbB-2 expression is predictive for lymphatic spread of clinical gastric carcinoma.
    Orita H; Maehara Y; Emi Y; Kakeji Y; Baba H; Korenaga D; Sugimachi K
    Hepatogastroenterology; 1997; 44(13):294-8. PubMed ID: 9058162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
    Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
    Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased HCRP1 expression is associated with poor prognosis in breast cancer patients.
    Xu J; Yang W; Wang Q; Zhang Q; Li X; Lin X; Liu X; Qin Y
    Int J Clin Exp Pathol; 2014; 7(11):7915-22. PubMed ID: 25550832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of prognostically unfavourable product of c-erbB-2 oncogene and EGF-R in carcinomas of the breast and uterine cervix.
    Ray A; Naik SL; Sharma BK
    Indian J Physiol Pharmacol; 2002 Oct; 46(4):423-33. PubMed ID: 12683217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the ERBB Family of Ligands and Receptors in Gastric Cancer.
    Byeon SJ; Lee HS; Kim MA; Lee BL; Kim WH
    Pathobiology; 2017; 84(4):210-217. PubMed ID: 28399526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.